Rawstron AC - Search Results

1

Early prediction of outcome and response to alemtuzumab therapy in chronic lymphocytic leukemia.

Rawstron AC, Kennedy B, Moreton P, Dickinson AJ, Cullen MJ, Richards SJ, Jack AS, Hillmen P. Rawstron AC, et al. Blood. 2004 Mar 15;103(6):2027-31. doi: 10.1182/blood-2002-10-3270. Epub 2003 Nov 20. Blood. 2004. PMID: 14630811 Free article.

2

Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).

Frolova EA, Richards SJ, Jones RA, Rawstron A, Master PS, Teasdale J, Short M, Jack AS, Scott CS. Frolova EA, et al. Leuk Lymphoma. 1995 Jan;16(3-4):307-18. doi: 10.3109/10428199509049770. Leuk Lymphoma. 1995. PMID: 7719238

3

Peripheral blood stem cell transplantation in myeloma using CD34 selected cells.

Johnson RJ, Owen RG, Smith GM, Child JA, Galvin M, Newton LJ, Rawstron A, Major K, Woodhead V, Robinson F, Jack A, Morgan GJ. Johnson RJ, et al. Bone Marrow Transplant. 1996 May;17(5):723-7. Bone Marrow Transplant. 1996. PMID: 8733688

4

Assessment of IgH PCR strategies in multiple myeloma.

Owen RG, Johnson RJ, Rawstron AC, Evans PA, Jack A, Smith GM, Child JA, Morgan GJ. Owen RG, et al. Among authors: rawstron ac. J Clin Pathol. 1996 Aug;49(8):672-5. doi: 10.1136/jcp.49.8.672. J Clin Pathol. 1996. PMID: 8881921 Free PMC article.

5

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.

Rawstron AC, Owen RG, Davies FE, Johnson RJ, Jones RA, Richards SJ, Evans PA, Child JA, Smith GM, Jack AS, Morgan GJ. Rawstron AC, et al. Br J Haematol. 1997 Apr;97(1):46-55. doi: 10.1046/j.1365-2141.1997.72653.x. Br J Haematol. 1997. PMID: 9136941 Free article.

6

Serum siliac acid in patients with multiple myeloma.

Richards SJ, Rawstron AC. Richards SJ, et al. Among authors: rawstron ac. Br J Biomed Sci. 1997 Mar;54(1):72. Br J Biomed Sci. 1997. PMID: 9167310 No abstract available.

7

p53 gene mutations in multiple myeloma.

Owen RG, Davis SA, Randerson J, Rawstron AC, Davies F, Child JA, Jack AS, Morgan GJ. Owen RG, et al. Among authors: rawstron ac. Mol Pathol. 1997 Feb;50(1):18-20. doi: 10.1136/mp.50.1.18. Mol Pathol. 1997. PMID: 9208809 Free PMC article.

8

A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis.

McGonagle D, Rawstron A, Richards S, Isaacs J, Bird H, Jack A, Morgan G, Emery P. McGonagle D, et al. Arthritis Rheum. 1997 Oct;40(10):1838-42. doi: 10.1002/art.1780401017. Arthritis Rheum. 1997. PMID: 9336419 Clinical Trial.

9

B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors.

Rawstron AC, Davies FE, Owen RG, English A, Pratt G, Child JA, Jack AS, Morgan GJ. Rawstron AC, et al. Br J Haematol. 1998 Jan;100(1):176-83. doi: 10.1046/j.1365-2141.1998.00525.x. Br J Haematol. 1998. PMID: 9450807 Free article.

10

Circulating primitive stem cells in paroxysmal nocturnal hemoglobinuria (PNH) are predominantly normal in phenotype but granulocyte colony-stimulating factor treatment mobilizes mainly PNH stem cells.

Johnson RJ, Rawstron AC, Richards S, Morgan GJ, Norfolk DR, Hillmen SO. Johnson RJ, et al. Among authors: rawstron ac. Blood. 1998 Jun 15;91(12):4504-8. Blood. 1998. PMID: 9616145 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters